COATS-VEGF

Clinical Trial

NCT03940690 Suspended

COATS-VEGF

Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease.

Phase 3

Interventional

Disease

Disease type

Paediatric clinical trials

Orphan drug recognition

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

24/10/2019

Closing date

01/11/2024

Inclusion criteria :

Exclusion criteria :

Funding

other

Members involved

Main investigators

Pr Dominique BREMOND-GIGNAC

Representative

France

Anterior Segment Rare Eye Diseases (WG4), CPMS & Digital Medecine (TWG10), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)

Working Group Leader